A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects

Posted on December 20, 2017 by hprdsadmin

Klaus Schaffler, MD, Ashraf Yassen, PhD, PharmD, Peter Reeh, MD, PhD,
and Paul Passier, PhD

ASP8477 Paper_FAAH_LEP_Caps

Pain Medicine Dec 2017   DOI:10.1093/pm/pnx281

This entry was posted in Clinical Studies. Bookmark the permalink.